Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hexaxim Booster Study in Latin American Infants
NCT01444781Phase 3Completed
- Sponsor
- Sanofi
- Start
- Sep 2011
- Primary completion
- Apr 2013
- Modality
- Recombinant Proteins and Enzymes, Vaccines & Immunotherapeutics
- Countries
- 2
01
Overview
A Phase 3 trial of hexaxim in diphtheria, Tetanus, pertussis, hepatitis B (HBV), poliomyelitis, sponsored by Sanofi. Started Sep 2011; status: completed.
02
Drugs
hexaxim
03
Conditions
diphtheriaTetanuspertussishepatitis B (HBV)poliomyelitis
Beyond the preview
Go deeper on NCT01444781.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01444781.